Ruiz Ares Gerardo, Martin Alonso Marta, Rigual Ricardo, Hervás Testal Carlos, Torres Iglesias Gabriel, Casado Fernandez Laura, de Celis Ruiz Elena, Rodríguez Pardo Jorge, Carvajal Muñoz Jenny, González Martín Laura, Alonso de Leciñana María, Fuentes Blanca
Department of Neurology and Stroke Centre, Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Autonomous University of Madrid), Madrid, Spain.
Speech and Language Therapy Unit, Rehabilitation Service, Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Autonomous University of Madrid), Madrid, Spain.
Digit Health. 2025 Jan 29;11:20552076251314551. doi: 10.1177/20552076251314551. eCollection 2025 Jan-Dec.
New technologies could play a role in post-stroke aphasia (PSA). Our aims were to develop a digital tool; to evaluate its acceptance and usability by patients and caregivers; and to demonstrate its effectiveness in improving language skills in patients with PSA, applying it from the acute phase.
The study consisted of two phases: development of a digital tool; and an interventional before-and-after study. During the first week of admission, the digital tool, VerbalizAPP, was installed for use with the help of family/caregivers. PSA was evaluated by a summarised version of the Boston Diagnostic Aphasia Examination (sBDAE) with 0-64 points. After 3 months of using VerbalizAPP, the sBDAE and scales to assess user satisfaction were applied.
Forty patients (29 men, mean age 68.3 years) were included. Aphasia description: Broca's 12 (15.0%), Wernicke's 13 (32.5%), mixed/global 15 (37.5%) cases. Patients began using VerbalizAPP 4.8 days (range 2-7) after stroke onset. A significant improvement in sBDAE scores was found after 3 months of VerbalizAPP use: 35.1 (SD 17.6) versus 51.1 (SD 14.4) points; < .001. Academic level was the only baseline parameter related to outcomes. Comfort of use scored 8.8, and complexity 2.2 points. Expectations were exceeded in 61.1%, and impression of improvement in 83.3% of cases. No adverse effects were reported, and all participants would recommend VerbalizAPP to other patients.
Our results show the effectiveness of VerbalizAPP for the treatment of PSA. However, larger prospective validation studies should be conducted to recommend its widespread use.
新技术可能在中风后失语症(PSA)中发挥作用。我们的目标是开发一种数字工具;评估患者和护理人员对其的接受度和可用性;并证明其在改善PSA患者语言技能方面的有效性,从急性期开始应用。
该研究包括两个阶段:数字工具的开发;以及一项前后对照干预研究。在入院的第一周,在家人/护理人员的帮助下安装数字工具VerbalizAPP以供使用。通过波士顿失语症诊断检查简版(sBDAE)对PSA进行评估,分数范围为0 - 64分。在使用VerbalizAPP 3个月后,应用sBDAE和评估用户满意度的量表。
纳入40例患者(29例男性,平均年龄68.3岁)。失语症类型:布罗卡失语12例(15.0%),韦尼克失语13例(32.5%),混合性/全面性失语15例(37.5%)。患者在中风发作后4.8天(范围2 - 7天)开始使用VerbalizAPP。使用VerbalizAPP 3个月后,sBDAE评分有显著改善:35.1(标准差17.6)分对51.1(标准差14.4)分;P <.001。学历水平是与结果相关的唯一基线参数。使用舒适度评分为8.8分,复杂度评分为2.2分。61.1%的患者超出预期,83.3%的患者有改善的印象。未报告不良反应,所有参与者都愿意向其他患者推荐VerbalizAPP。
我们的结果表明VerbalizAPP治疗PSA有效。然而,应进行更大规模的前瞻性验证研究以推荐其广泛使用。